Literature DB >> 19930398

Recommendations for performing and evaluating the results of the minor test according to a sweating intensity visual scale.

Doris Hexsel1, Ticiana C Rodrigues, Mariana Soirefmann, Debora Zechmeister-Prado.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19930398     DOI： 10.1111/j.1524-4725.2009.01364.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN： 1076-0512            Impact factor:   3.398


× No keyword cloud information.
  6 in total

1.  Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial.

Authors:  A Campanati; K Giuliodori; E Martina; A Giuliano; G Ganzetti; A Offidani
Journal:  J Neural Transm (Vienna)       Date:  2013-09-20       Impact factor: 3.575

2.  Ross Syndrome.

Authors:  Manikanta Damagatla; Pratyusha Ganne; Rakesh Upparakadiyala; Prabhakaran N
Journal:  Neuroophthalmology       Date:  2019-12-12

3.  Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature.

Authors:  Anna Campanati; Emanuela Martina; Stamatis Gregoriou; George Kontochristopoulos; Matteo Paolinelli; Federico Diotallevi; Giulia Radi; Ivan Bobyr; Barbara Marconi; Giulio Gualdi; Paolo Amerio; Annamaria Offidani
Journal:  Toxins (Basel)       Date:  2022-05-27       Impact factor: 5.075

4.  Delusional hyperhidrosis: A case report and recommendations for management.

Authors:  Megan V Ha; Sherry H Yu
Journal:  JAAD Case Rep       Date:  2022-09-22

5.  Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands.

Authors:  Yiyu Wang; Jörg Scheffel; Carolina Ayala Vera; Wei Liu; Dorothee Günzel; Dorothea Terhorst-Molawi; Marcus Maurer; Sabine Altrichter
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

6.  Treatment of primary axillary hyperhidrosis with botulinum toxin type a: our experience in 50 patients from 2007 to 2010.

Authors:  Stefano Scamoni; Luigi Valdatta; Claudia Frigo; Francesca Maggiulli; Mario Cherubino
Journal:  ISRN Dermatol       Date:  2012-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.